News feed on Vet Dx
Monday, February 14, 2022
February 14, 2022 at 04:11PM ATryn
Product approval information is indicated for the prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/eprPEax
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment